This individual will support the U.S. HCP brand strategy through commercialization, ensuring clear differentiation, compelling scientific communication, and flawless execution across channels. The role will work closely cross-functional partners deliver an integrated experience for HCPs and ensure brand continuity across tactics.
This is a high-impact, high-visibility role within a fast-growing organization and an opportunity to contribute to the commercial foundation of Scholar Rock’s first marketed product.
Position Responsibilities
U.S. HCP Execution
- Support execution of the U.S. HCP brand strategy for apitegromab, grounded in deep understanding of the SMA landscape, unmet need, and clinical data.
- Translate strategy into high-quality, compliant HCP promotional tactics across personal and non-personal channels.
- Partner with field-based team members to ensure strong integration between HCP marketing and field execution.
- Collaborate with agency partners and vendors to deliver best-in-class creative and execution.
Cross-Functional Leadership
- Serve as a connector across the U.S. Commercial Team, collaborating with Medical Affairs, Market Access, Patient Services, Regulatory, Legal, and Compliance.
- Build strong relationships with cross-functional partners in order to ensure brand continuity across all HCP-facing materials and tactics.
Candidate Qualifications
- Bachelor’s degree required; advanced degree preferred.
- 3+ years of experience in pharmaceutical or biotechnology marketing, with experience in U.S. HCP marketing or Medical Education preferred
- MLR (or equivalent) experience strongly preferred.
- Understanding and experience navigating compliant HCP messaging.
- Strong strategic mindset with hands-on execution capability.
- Experience working in matrixed, cross-functional teams in a fast-paced environment.
- Excellent communication, influence, and stakeholder-management skills.
- Experience in neurology, neuromuscular disease, or rare disease preferred.
- Willingness to travel as needed (anticipated up to ~30%).